Turning Point Therapeutic...

NASDAQ: TPTX · Real-Time Price · USD
75.49
0.09 (0.12%)
At close: Aug 15, 2022, 10:00 PM

Turning Point Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-342.31M -275.49M -236.55M -205.48M -156.86M -132.08M
Depreciation & Amortization
5.05M 4.59M 3.97M 3.3M 2.69M 2.44M
Stock-Based Compensation
60.38M 56.37M 58.56M 54.2M 48.97M 43.08M
Other Working Capital
12.4M 12.34M 14.38M 10.93M 5.69M 7.93M
Other Non-Cash Items
3.98M 4.83M 5.33M 5.18M 4.27M 2.9M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a
Change in Working Capital
13.44M 13.18M 14.81M 9.7M 11.23M 13.05M
Operating Cash Flow
-259.44M -196.53M -153.88M -133.11M -89.7M -70.61M
Capital Expenditures
-3.53M -2.73M -2.43M -2.43M -1.43M -953K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a
Purchase of Investments
-348M -413.36M -439.23M -659.15M -756.05M -715.95M
Sales Maturities Of Investments
460.72M 440.07M 447.12M 420.84M 338.92M 418.45M
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a
Investing Cash Flow
109.19M 23.98M 5.46M -240.74M -418.55M -298.45M
Debt Repayment
n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
4.98M 14.72M 24M 467.57M 465.59M 808.39M
Financial Cash Flow
14.35M 14.72M 24M 467.57M 465.59M 808.39M
Net Cash Flow
-135.9M -157.76M -124.35M 93.8M -42.59M 439.33M
Free Cash Flow
-262.97M -199.26M -156.31M -135.54M -91.13M -71.56M